Inspiration Healthcare Group
plc
("Inspiration Healthcare", the "Company"
or the "Group")
Appointment of Chief
Executive Officer
Inspiration Healthcare Group plc
(AIM: IHC), the global medical technology company
pioneering best-in-class, specialist neonatal intensive care
medical devices, announces the appointment of Harout
Rafi ("Raffi") Stepanian as CEO and a Director of the Company,
effective from 8 January 2025. Roy Davis will then return to
the role of Non-Executive Chairman.
Raffi is an experienced and
commercially focused healthcare industry professional, with
extensive operational experience within fast-growing international
medical device companies. His areas of expertise include
respiratory, anaesthesia and monitoring and he has a reputation for
a hands-on approach to management and delivery of results.
Raffi has held a number of senior management roles over the
last 20 years and has significant international experience in the
ventilator market.
Most recently Raffi was CEO of Breas
Medical, a Swedish based global medical device company designing,
manufacturing, and marketing ventilation devices for home and
hospital use. During his four-year tenure he was responsible for
transformational change improving turnover and profitability while
successfully launching new products in the US with experience in
navigating the FDA regulatory processes. Prior to this, he held a
leadership position at GE Healthcare where he was responsible for
setting the product growth strategy, value proposition and
marketing activities in the anaesthesia and ventilation
segment.
Roy
Davis, Executive Chairman of Inspiration Healthcare
said: "We are delighted to welcome Raffi on board,
and we look forward to him joining the Inspiration team. He has
been instrumental in developing industry-leading respiratory
solutions in his past roles and has a track record of delivery.
Raffi brings significant international commercial expertise
including successful US product launches. We believe Raffi has the
right skillset to execute on our future plans and deliver long term
value to shareholders and I look forward to working with
him."
Raffi Stepanian, incoming Chief Executive Officer
commented: "I am thrilled to be
joining Inspiration Healthcare at a stage in the Group's
development where they are turning a corner and now have
a clear strategy
to return the business to growth. Inspiration has
significant potential, with world class design and manufacturing
expertise and a broad range of innovative best-in-class medical
products. There are also exciting growth opportunities in new
markets. I'm looking forward to working with Roy, the Board, and
the Inspiration Healthcare team to deliver on the opportunity."
In accordance with Schedule 2 (g) of
the AIM Rules for Companies, Harout Rafi Stepanian (aged 55 years)
holds / has held the following directorships/partnerships in the
last five years:
Current directorships / partnerships
|
Previous directorships / partnerships in last 5
years
|
None
|
Breas Medical Holdings AB
|
|
|
Harout Rafi Stepanian does not hold
any ordinary shares in the capital of the Company. There are
no further disclosures to be made in accordance with AIM Rule 17 or
Schedule 2(g) of the AIM Rules for Companies.
For further
information, please contact:
Inspiration Healthcare Group plc
|
Tel: +44 (0)330 175 0000
|
Roy Davis, Executive Chair and
Interim CEO
Alan Olby, Chief Financial
Officer
|
|
|
|
Panmure Liberum (Nominated Adviser &
Broker)
|
Tel: +44 (0)20 3100 2000
|
Richard Lindley
Will King
|
|
|
|
Walbrook PR
Ltd (Media and Investor Relations)
|
Tel: +44 (0)20 7933
8780 or inspirationhealthcare@walbrookpr.com
|
Anna Dunphy
|
Mob: +44 (0) 7876 741
001
|
Louis Ashe-Jepson
|
Mob: +44 (0) 7747 515
393
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC)
designs, manufactures and markets pioneering medical
technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical
need to help to save the lives and improve the outcomes of
patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own
products and complementary distributed
products, for use in neonatal intensive care designed
to support even the most premature babies throughout their hospital
stay. Its own branded products range from highly sophisticated
capital equipment such as ventilators for life support through to
single-use disposables.